aod-9604 vs tirzepatide for weight loss Understanding AOD 9604: The Science of the “Fat-Burning” Peptide Fragment aod9604 peptides AOD 9604 Injection

These are population-level results across a large, diverse trial cohort

The 1mg group lost an average of 2.8 kilograms compared to 0.8 kilograms in the placebo group

Dietary management becomes essential on tirzepatide, not optional

Each missed dose represents a gap in the protocol that may reduce cumulative results

How clinics can position AOD 9604 ethically If your clinic is focused on patient care, the most sustainable approach is to position AOD 9604 as a supportive option within a supervised program, not as a guaranteed fat loss injection

In theory, there is no direct pharmacological conflict between these pathways